Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720338 · ClinicalTrials.gov registry record · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
A Phase 3 study of Pancreatectomy and Cyst of Pancreas, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 234
- Enrollment target
- 1
- Study location
NCT05720338: Recruiting Phase 3 study of Pancreatectomy and Cyst of Pancreas, sponsored by Case Comprehensive Cancer Center.
NCT05720338 is a Phase 3 study of Pancreatectomy and Cyst of Pancreas that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 234 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05720338, a Phase 3 study of Pancreatectomy and Cyst of Pancreas, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 234 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drainage with respect to a composite post-operative complications of Grade B or C Postoperative pancreatic fistula (POPF), readmission, or organ space surgical site infection following a distal pancreatectomy.
Primary Outcome
Comparison between groups using a composite endpoint of complications that includes presence of Grade B POPF
Conditions Studied
Interventions
- DEVICE 19 French Blake Drain
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2023-04-13 |
| Est. Completion | 2027-07-31 |
| Phase | Phase 3 |
What NCT05720338 shows while recruiting
NCT05720338 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower).
The record links to 3 conditions, with Pancreatectomy appearing as the primary indexed condition, and to 1 intervention - of which 19 French Blake Drain is the first listed.
NCT05720338 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05720338 about?
NCT05720338 is a clinical study titled "Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?". The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drai...
What is the current status of trial NCT05720338?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 234 participants. The study started on 2023-04-13. Estimated completion is 2027-07-31.
What conditions does trial NCT05720338 study?
This clinical trial studies the following conditions: Pancreatectomy, Cyst of Pancreas, Pancreas Neoplasm.
What interventions are being tested in trial NCT05720338?
The interventions under investigation include: 19 French Blake Drain (DEVICE).
Who is sponsoring clinical trial NCT05720338?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720338 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05720338's enrollment target sits among peer trials
234 1298th of 2000 higher than 703 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT06047301 · 234 participants · NA
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI